Literature DB >> 22178111

Obesity and breast cancer: a clinical biochemistry perspective.

Amitabha Ray1, Margot P Cleary.   

Abstract

OBJECTIVES: To evaluate the laboratory diagnosis aspects of obesity-related health problems with special reference to postmenopausal breast cancer. DESIGN AND METHODS: We conducted a systemic search of the literature primarily from the PubMed to obtain the relevant data.
RESULTS: Obesity is associated with the dysregulations of a number of body components such as blood constituents, extracellular matrix, and hormones/growth factors axes, which could be utilized for early diagnosis.
CONCLUSIONS: Obesity-related disorders including breast cancer have emerged as major health problems in almost all the nations. There is a need to elucidate different biochemical markers that are being used in the clinics or have the potential for such use. A precise understanding of the complex pathologies related with obesity is useful in prevention, early diagnosis and overall clinical management.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178111     DOI: 10.1016/j.clinbiochem.2011.11.016

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

Review 1.  Adipokine leptin in obesity-related pathology of breast cancer.

Authors:  Amitabha Ray
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

2.  Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation.

Authors:  Nadine A Binai; Gert Carra; Johannes Löwer; Roswitha Löwer; Silja Wessler
Journal:  Endocrine       Date:  2013-02-15       Impact factor: 3.633

3.  Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

Review 4.  Multifaceted leptin network: the molecular connection between obesity and breast cancer.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-10       Impact factor: 2.673

5.  Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer.

Authors:  Erin D Giles; Elizabeth A Wellberg; David P Astling; Steven M Anderson; Ann D Thor; Sonali Jindal; Aik-Choon Tan; Pepper S Schedin; Paul S Maclean
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

6.  Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.

Authors:  LaTonia Taliaferro-Smith; Arumugam Nagalingam; Brandi Brandon Knight; Elaine Oberlick; Neeraj K Saxena; Dipali Sharma
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

Review 7.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

8.  Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.

Authors:  Lin Wang; Cuiping Tang; Hong Cao; Kuangfa Li; Xueli Pang; Liang Zhong; Weiqi Dang; Hao Tang; Yunxiu Huang; Lan Wei; Min Su; Tingmei Chen
Journal:  Cancer Biol Ther       Date:  2015-06-29       Impact factor: 4.742

9.  Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.

Authors:  Adel M A Assiri; Hala F M Kamel; Mohamed F R Hassanien
Journal:  Dis Markers       Date:  2015-03-08       Impact factor: 3.434

10.  Promoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): study protocol for a randomized controlled trial.

Authors:  Patrizia Gnagnarella; Daniele Dragà; Federica Baggi; Maria Claudia Simoncini; Annarita Sabbatini; Ketti Mazzocco; Fabio Domenico Bassi; Gabriella Pravettoni; Patrick Maisonneuve
Journal:  Trials       Date:  2016-07-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.